Ignite Creation Date:
2025-12-24 @ 7:21 PM
Ignite Modification Date:
2026-02-25 @ 6:35 PM
Study NCT ID:
NCT04081103
Status:
TERMINATED
Last Update Posted:
2025-07-14
First Post:
2019-08-29
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
NEXAGON for the Treatment of Corneal Persistent Epithelial Defects Following Severe Ocular Injuries
Sponsor:
Glaukos Corporation
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Corneal Persistent Epithelial Defect | View |
Keywords: